SEC Form 4 · accession 0001415889-15-002910
MABVAX THERAPEUTICS HOLDINGS, INC. · MBVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth M Cohen
Director
Period of report
Aug 26, 2015
Accepted (ET)
Aug 27, 2015 · 3:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001109196
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $1.52 | Aug 26, 2015 | A | 35,000 | A | — | Aug 26, 2025 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1Option vests and becomes exercisable one year after the date of grant.